Category: Molecular Biology
Molecular Biology market research reports by Kalorama Information
-
The Worldwide Market for Liquid Biopsy, 6th Edition
The Worldwide Market for Liquid Biopsy, 6th Edition Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imagin ... Read More
-
Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028 In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare. For example, next-generation sequencing ( ... Read More
-
The Market and Future Potential for Molecular Point of Care (mPOC), 2023
The Market and Future Potential for Molecular Point of Care (mPOC), 2023 This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market. The instruments sold by A ... Read More
-
The World Market for Liquid Biopsy, 2023
The World Market for Liquid Biopsy, 2023 Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the Liquid Biopsy Market now and in 2027. The report can be useful for business plan ... Read More
-
The Market for Liquid Biopsy
The Market for Liquid Biopsy This report, The World Liquid Biopsy Market, 2021, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by T ... Read More
-
The Market and Future Potential for Molecular Point of Care
The Market and Future Potential for Molecular Point of Care This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies s ... Read More
-
Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)
Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests) Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examine ... Read More
-
The World Liquid Biopsy Market
The World Liquid Biopsy Market Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. This report, The World Liquid Biop ... Read More
-
PCR Markets for Life Sciences Applications (Market by Type - qPCR, dPCR - Application - Pharmaceutical, General Research, and by Country and Region)
PCR Markets for Life Sciences Applications (Market by Type - qPCR, dPCR - Application - Pharmaceutical, General Research, and by Country and Region) As part of its coverage of this market, Kalorama Information's report provides: The Market for Life Sciences PCR, 2017 to 2022 Application Market Segme ... Read More
-
Cancer Liquid Biopsy Market Assessment
Cancer Liquid Biopsy Market Assessment (Breast Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer) The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring ... Read More
-
The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer)
The Worldwide Market for Liquid Biopsy This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, screening, drug monitoring. Companies are profiled an ... Read More
-
Clinical Diagnostics PCR Markets by Type (Infectious Disease, Cancer, Cardiovascular, Genetic, Others) and Region (U.S., Europe, Japan, China, Latin America, World) and Technology (PCR, TMA, Other NAAT)
The PCR testing market, which includes other NAAT technologies, is a large and diverse market. This market consists of three segments: the life science (research) NAAT market, the clinical NAAT market, and an "other" segment that includes forensics, environmental monitoring, veterinary, and other ... Read More
-
PCR Market for Life Sciences and Diagnostics (qPCR & dPCR, TMA and Other NAAT)
PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) Polymerase chain reaction (PCR) technology is used in life science (research) activities and also in clinical medicine. PCR Testing Market for Life Sciences and Diagnostics (qPCR, dPCR and other NAAT) includes opportun ... Read More
-
qPCR and dPCR Markets (Instruments, Reagents, Software/Services)
qPCR and dPCR Markets (Instruments, Reagents, Software/Services) This Kalorama Information study, qPCR and dPCR, analyzes the market for these workhorse technnologies in detail, providing detailed market sizing and forecasts for both the research and clinical PCR market are provided to 2020. Trends ... Read More
Research Assistance
